C07D 265/04
1,3-oxazines
Official title: 1,3-Oxazines; Hydrogenated 1,3-oxazines
C07D265/04 (1,3-oxazines) appears on 852 US grants and 628 published applications in this corpus.
Search patents in C07D- Granted patents
- 852
- Published applications
- 628
- Assignees
- 399
- Inventors
- 2,214
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 18 | 0 |
| 1977 | 22 | 0 |
| 1978 | 13 | 0 |
| 1979 | 15 | 0 |
| 1980 | 22 | 0 |
| 1981 | 21 | 0 |
| 1982 | 29 | 0 |
| 1983 | 15 | 0 |
| 1984 | 15 | 0 |
| 1985 | 18 | 0 |
| 1986 | 12 | 0 |
| 1987 | 12 | 0 |
| 1988 | 11 | 0 |
| 1989 | 8 | 0 |
| 1990 | 9 | 0 |
| 1991 | 9 | 0 |
| 1992 | 10 | 0 |
| 1993 | 12 | 0 |
| 1994 | 6 | 0 |
| 1995 | 11 | 0 |
| 1996 | 12 | 0 |
| 1997 | 20 | 0 |
| 1998 | 16 | 0 |
| 1999 | 19 | 0 |
| 2000 | 26 | 0 |
| 2001 | 11 | 4 |
| 2002 | 28 | 24 |
| 2003 | 20 | 44 |
| 2004 | 23 | 31 |
| 2005 | 17 | 27 |
| 2006 | 13 | 36 |
| 2007 | 14 | 25 |
| 2008 | 16 | 15 |
| 2009 | 14 | 31 |
| 2010 | 27 | 47 |
| 2011 | 19 | 43 |
| 2012 | 31 | 39 |
| 2013 | 29 | 28 |
| 2014 | 35 | 18 |
| 2015 | 28 | 25 |
| 2016 | 13 | 32 |
| 2017 | 25 | 19 |
| 2018 | 23 | 29 |
| 2019 | 16 | 17 |
| 2020 | 11 | 16 |
| 2021 | 25 | 13 |
| 2022 | 4 | 12 |
| 2023 | 9 | 17 |
| 2024 | 2 | 20 |
| 2025 | 13 | 10 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Benzoxazine derivatives vitrimers28 Apr 2026US 12,612,373 B2Luxembourg Institute of Science and Technology (List)
- Benzoxazine compound, resin raw material composition containing the same, curable resin composition, and cured product thereof28 Apr 2026US 12,612,393 B2Honshu Chemical Industry Co., Ltd.
- Benzoxazine compound-containing composition, curable resin composition, and cured product thereof17 Mar 2026US 12,577,346 B2Honshu Chemical Industry Co., Ltd.
- Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors17 Mar 2026US 12,581,252 B2D. E. Shaw Research, LLC
- Process for preparing isoindolinone derivative, novel intermediates used for the process, and a process for preparing the intermediates3 Feb 2026US 12,540,123 B2Cng Bio Co., Ltd.
- Raf-mek protein complex modulators and methods of use thereof1 Oct 2026US 2026/0297105 A1Gandeeva Therapeutics, Inc.
- Compounds for positive modulation of the autophagy-lysosomal pathway and methods of use27 Aug 2026US 2026/0250256 A1
- (n-alkyldihydrol-2h-oxazinyl)-cannabidiol as anti-proliferative agent and process for preparation thereof30 Jul 2026US 2026/0216216 A1
- Dual curable vitrimers23 Jul 2026US 2026/0209433 A1Luxembourg Institute of Science and Technology (List)
- Pi3k-alpha inhibitors and methods of use thereof16 Jul 2026US 2026/0205746 A1D. E. Shaw Research, LLC
Most cited
By later US patents
- 6-amino-1,4-dihydro-benzo[d][1,3] oxazin-2-ones and analogs useful as progesterone receptor modulators251US 7,247,625 B2Wyeth · 2007
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995
- Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase198US 5,710,158 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1998
- Method for preparation of taxol using an oxazinone181US 5,015,744 AFlorida State University · 1991